Research

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117174/

Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review February 27, 2021

https://journals.lww.com/cogbehavneurol/Abstract/2013/03000/Neuropsychiatric_Autoimmune_Encephalitis_without.7.aspx

Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab February 27, 2021

https://jamanetwork.com/journals/jamaneurology/fullarticle/1697440

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897696/

Insights from LGI1 and CASPR2 potassium channel complex antibody subtyping February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895328/

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806918/

Autoimmune encephalitis: Recent updates and emerging challenges February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/24246947